| Date | Event | Description |
|---|---|---|
| 17 June 2010 | New search has been performed | New search February 2010 |
| 5 March 2010 | New citation required but conclusions have not changed | One new study identified and included in analyses, increasing number of participants treated with lumira-coxib 400 mg by 73%. Conclusions are unchanged, but confidence in results is increased |
| 7 November 2008 | Amended | Minor change to in-house referencing code |
| 6 May 2008 | Amended | Converted to new review format. |
| 24 January 2008 | Amended | On November 2007 the UK Medicines and Healthcare Regulatory Authority suspended the marketing authorisation for Lumiracoxib following safety concerns relating to liver damage in patients prescribed the drug for chronic/long term condiions such as osteoarthritis |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.